KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Asset Writedowns and Impairment: 2020-2025

Historic Asset Writedowns and Impairment for Twist Bioscience (TWST) over the last 6 years, with Sep 2025 value amounting to -$20,000.

  • Twist Bioscience's Asset Writedowns and Impairment fell 80.89% to $293,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $940,000, marking a year-over-year decrease of 63.47%. This contributed to the annual value of -$20,000 for FY2025, which is 102.13% down from last year.
  • As of FY2025, Twist Bioscience's Asset Writedowns and Impairment stood at -$20,000, which was down 102.13% from $940,000 recorded in FY2024.
  • Twist Bioscience's Asset Writedowns and Impairment's 5-year high stood at $20.1 million during FY2022, with a 5-year trough of -$20,000 in FY2025.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $940,000 (2024), whereas its average is $1.2 million.
  • Per our database at Business Quant, Twist Bioscience's Asset Writedowns and Impairment surged by 797.33% in 2022 and then slumped by 102.13% in 2025.
  • Over the past 5 years, Twist Bioscience's Asset Writedowns and Impairment (Yearly) stood at $2.2 million in 2021, then soared by 797.33% to $20.1 million in 2022, then crashed by 87.22% to $2.6 million in 2023, then slumped by 63.47% to $940,000 in 2024, then slumped by 102.13% to -$20,000 in 2025.